Walter Tilmann
Institut für Geschichte der Medizin, Julius-Maximilians-Universität Würzburg.
Wurzbg Medizinhist Mitt. 2008;27:381-408.
Historians of early modern medicine have frequently portrayed Paracelsians and Antiparacelsians around 1600 as two largely separate, hostile factions locked in a fierce battle. As I will argue in my paper, this account attributes too much weight to the public self-fashioning of both groups: From the mid-16th century onwards, some physicians chose the deceased Theophrastus of Hohenheim, or Paracelsus, as their new medical hero and tried to attract affluent patients with new, supposedly more powerful "spagyric" medicaments. Other physicians showed intense interest without thereby accepting Paracelsus as the "Luther of medicine". Based on my analysis of large collections of early modern physicians' letters, I argue for a more nuanced and cautious account of this conflict. Well-known physicians like Konrad Gesner, Johann Crato von Krafftheim, or Joachim Camerarius did indeed condemn the arrogance and rudeness of Paracelsus and his belittling of the ancient medical authors. Yet, at the same time, they also showed a keen interest in the new chemical drugs which the "Paracelsians" promoted. None of these supposed "Antiparacelsians" supported or welcomed the vehement attacks by Thomas Erastus in his Disputationum de Medicina nova Paracelsi without reservations--although Erastus suggested this for tactical reasons.
近代早期医学史学家常常将1600年前后的帕拉塞尔苏斯派和反帕拉塞尔苏斯派描绘成两个大体上相互独立、充满敌意的派别,陷入了一场激烈的斗争。正如我将在论文中论述的,这种说法过于看重两派在公众面前的自我塑造:从16世纪中叶起,一些医生选择已故的霍恩海姆的泰奥弗拉斯托斯,即帕拉塞尔苏斯,作为他们新的医学英雄,并试图用新的、据称更有效的“炼金术”药物吸引富裕的病人。其他医生表现出浓厚的兴趣,但并没有因此将帕拉塞尔苏斯奉为“医学上的路德”。基于我对大量近代早期医生信件的分析,我主张对这场冲突进行更细致、更谨慎的描述。像康拉德·格斯纳、约翰·克拉托·冯·克拉夫特海姆或约阿希姆·卡梅拉里乌斯这样的知名医生确实谴责了帕拉塞尔苏斯的傲慢和粗鲁以及他对古代医学作者的贬低。然而,与此同时,他们也对“帕拉塞尔苏斯派”所推崇的新化学药物表现出浓厚的兴趣。这些所谓的“反帕拉塞尔苏斯派”中没有一个人毫无保留地支持或欢迎托马斯·埃拉斯图斯在其《关于新帕拉塞尔苏斯医学的争论》中的激烈抨击——尽管埃拉斯图斯出于策略原因提出了这样的建议。